Bank of Montreal’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-70,352
| Closed | -$232K | – | 4142 |
|
|
2024
Q2 | $232K | Sell |
70,352
-37,548
| -35% | -$165K | ﹤0.01% | 2901 |
|
|
2024
Q1 | $605K | Buy |
107,900
+26,500
| +33% | +$143K | ﹤0.01% | 2315 |
|
|
2023
Q4 | $357K | Buy |
+81,400
| New | +$270K | ﹤0.01% | 2751 |
|
|
2023
Q1 | – | Sell |
-32,265
| Closed | -$148K | – | 4081 |
|
|
2022
Q4 | $148K | Buy |
+32,265
| New | +$111K | ﹤0.01% | 3258 |
|
|
2022
Q1 | – | Sell |
-557,538
| Closed | -$1.82M | – | 4256 |
|
|
2021
Q4 | $1.82M | Buy |
557,538
+304,475
| +120% | +$1.32M | ﹤0.01% | 1628 |
|
|
2021
Q3 | $1.85M | Sell |
253,063
-10,229
| -4% | -$76.6K | ﹤0.01% | 2120 |
|
|
2021
Q2 | $2.58M | Buy |
263,292
+132,501
| +101% | +$1.34M | ﹤0.01% | 1929 |
|
|
2021
Q1 | $1.23M | Sell |
130,791
-61,790
| -32% | -$690K | ﹤0.01% | 2043 |
|
|
2020
Q4 | $2.22M | Sell |
192,581
-70,388
| -27% | -$713K | ﹤0.01% | 1776 |
|
|
2020
Q3 | $2.69M | Sell |
262,969
-22,097
| -8% | -$225K | ﹤0.01% | 1544 |
|
|
2020
Q2 | $2.92M | Buy |
285,066
+94,228
| +49% | +$975K | ﹤0.01% | 1444 |
|
|
2020
Q1 | $1.4M | Buy |
190,838
+168,931
| +771% | +$1.64M | ﹤0.01% | 1583 |
|
|
2019
Q4 | $192K | Buy |
21,907
+7,981
| +57% | +$66.1K | ﹤0.01% | 3181 |
|
|
2019
Q3 | $150K | Buy |
13,926
+11,324
| +435% | +$122K | ﹤0.01% | 3083 |
|
|
2019
Q2 | $33K | Buy |
2,602
+2,218
| +578% | +$51.1K | ﹤0.01% | 3889 |
|
|
2019
Q1 | $15K | Sell |
384
-28
| -7% | -$855 | ﹤0.01% | 3756 |
|
|
2018
Q4 | $8K | Buy |
412
+211
| +105% | +$6.33K | ﹤0.01% | 3949 |
|
|
2018
Q3 | $9K | Sell |
201
-1,408
| -88% | -$67.9K | ﹤0.01% | 3955 |
|
|
2018
Q2 | $95K | Buy |
1,609
+227
| +16% | +$13.2K | ﹤0.01% | 3143 |
|
|
2018
Q1 | $94K | Sell |
1,382
-20,214
| -94% | -$1.51M | ﹤0.01% | 2986 |
|
|
2017
Q4 | $2.13M | Sell |
21,596
-72,650
| -77% | -$8.13M | ﹤0.01% | 1547 |
|
|
2017
Q3 | $11.3M | Buy |
94,246
+88,895
| +1,661% | +$8.27M | 0.01% | 808 |
|
|
2017
Q2 | $468K | Buy |
5,351
+97
| +2% | +$5.43K | ﹤0.01% | 2305 |
|
|
2017
Q1 | $195K | Buy |
+5,254
| New | +$192K | ﹤0.01% | 2486 |
|
|
2016
Q1 | – | Sell |
-195
| Closed | -$15K | – | 4347 |
|
|
2015
Q4 | $15K | Buy |
195
+185
| +1,850% | +$14.5K | ﹤0.01% | 3500 |
|
|
2015
Q3 | $1K | Sell |
10
-359
| -97% | -$34K | ﹤0.01% | 3883 |
|
|
2015
Q2 | $43K | Buy |
369
+361
| +4,513% | +$65.4K | ﹤0.01% | 3053 |
|
|
2015
Q1 | $2K | Sell |
8
-1,710
| -100% | -$366K | ﹤0.01% | 3791 |
|
|
2014
Q4 | $325K | Sell |
1,718
-4,437
| -72% | -$984K | ﹤0.01% | 2265 |
|
|
2014
Q3 | $1.47M | Buy |
6,155
+5,555
| +926% | +$1.14M | ﹤0.01% | 1597 |
|
|
2014
Q2 | $40K | Buy |
+600
| New | +$42.7K | ﹤0.01% | 3302 |
|
Other funds holding PBYI
FLSM
EP
ACM
Bank of Montreal's PBYI Position: Q3 2024 in Review
Bank of Montreal sold out of Puma Biotechnology (PBYI) in Q3 2024, closing a stake of 70,352 shares — an estimated $232K sold.
Bank of Montreal first reported a position in PBYI in Q2 2014 and held it in 31 quarters. The position peaked at $11.3M in Q3 2017. 100 funds tracked by Wall St. Rank hold PBYI as of Q3 2024.
- Bank of Montreal reported no remaining Puma Biotechnology position as of Q3 2024 after selling out during the quarter.
- Bank of Montreal sold 70,352 Puma Biotechnology shares in Q3 2024, an estimated $232K.
- Bank of Montreal first reported a position in Puma Biotechnology in Q2 2014 and held it in 31 quarters.
- Bank of Montreal's Puma Biotechnology position peaked at $11.3M in Q3 2017.
- 100 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2024.
Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.